unbanked ranks 5th in 'rising buy forecasts' among individual investors on Minkabu
As of 1:00 p.m. on the 3rd, unbanked inc. <8746> ranked fifth in the rising buy forecasts category of Minkabu's Retail Investor Forecasts (Latest 48 Hours).
The stock extended a sharp rally in Tokyo trading following a limit-up session the previous day. unbanked announced at about 9:50 a.m. on the 2nd that it resumed its gold bullion business, which was temporarily suspended during a bank account withdrawal freeze. Lifting the restriction eased concerns over its outlook, driving buy forecasts higher.
A former representative director, removed at a board meeting on July 17, filed a petition with the Tokyo District Court on Aug. 7 seeking a provisional injunction to suspend the current representative director's duties, claiming the resolution was invalid. Through legal counsel, the former director requested Aug. 19 that unbanked's major banks freeze account withdrawals, and the banks complied. However, the Tokyo District Court dismissed the petition on Aug. 31. After unbanked explained the situation to banks, the withdrawal freeze was lifted effective Sept. 2.
*Translated by generative AI. Click here for the original article.
Related Articles
-
ULVAC rebounds for first time in four sessions after Eastspring Investments discloses stake of over 6%
Thu Sep 3, 2026 2:18 pm JST Catalyst -
Lasertec gains in afternoon session as optimism grows over EUV lithography development race
Thu Sep 3, 2026 2:09 pm JST Catalyst -
Market breadth at 2 p.m.: 954 gainers vs. 538 decliners on TSE Prime
Thu Sep 3, 2026 2:04 pm JST Market -
NIPPON PAINT HOLDINGS rebounds for first time in three sessions as domestic brokerage raises target price to 1,550 yen
Thu Sep 3, 2026 1:46 pm JST Catalyst -
INPEX extends losses as WTI crude briefly falls below $91 in after-hours trading
Thu Sep 3, 2026 1:39 pm JST Catalyst -
ASAHI extends losses as August same-store sales fall for second straight month
Thu Sep 3, 2026 1:29 pm JST Catalyst -
Eisai rebounds after lecanemab subcutaneous formulation approved in China as initial therapy for early AD
Thu Sep 3, 2026 1:26 pm JST Catalyst -
Market breadth at 1 p.m.: 978 gainers vs. 509 decliners on TSE Prime
Thu Sep 3, 2026 1:04 pm JST Market -
EXTREME rebounds as subsidiary to make world premiere of new 'Lollipop Chainsaw' title at TGS
Thu Sep 3, 2026 1:01 pm JST Catalyst -
JTEKT rises to 5th place in 'rising buy forecasts' ranking on Minkabu
Thu Sep 3, 2026 12:53 pm JST Catalyst